Nektar Therapeutics
LONG-ACTING INTERLEUKIN-15 RECEPTOR AGONISTS AND RELATED IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS
Last updated:
Abstract:
The instant disclosure provides a long acting IL-15 receptor agonist, related compositions and methods of preparation and use, for example, in the treatment of conditions responsive to therapy effective to provide, for example, sustained immune activation and/or anti-tumor activity.
Status:
Application
Type:
Utility
Filling date:
15 May 2018
Issue date:
12 Mar 2020